نتایج جستجو برای: spondyloarthropathy

تعداد نتایج: 672  

2003
P Verschueren R Westhovens

Historically, AA amyloidosis accounts for almost half of the deaths among patients with juvenile chronic arthritis, mainly due to complications of end stage renal failure. Improved survival has been reported in patients whose underlying inflammatory disorder was brought to remission. Tumour necrosis factor (TNFα) blocking agents have been used successfully in the treatment of inflammatory disor...

Journal: :Modern rheumatology 2014
Kiyoshi Migita Seigo Abiru Osamu Sasaki Taiichiro Miyashita Yasumori Izumi Ayako Nishino Yuka Jiuchi Atsushi Kawakami Michio Yasunami

Familial Mediterranean fever (FMF) is an autoinflammatory disorder characterized by recurrent febrile polyserositis and arthritis. Although accompanying seronegative spondyloarthropathy has been reported in FMF, coexistence with rheumatoid arthritis (RA) is very rare. This case report describes a Japanese female RA patient who presented with periodic fever. Genetic analysis revealed compound he...

2017
Anja Weiß Kirsten Minden Joachim Listing Ivan Foeldvari Joachim Sieper Martin Rudwaleit

OBJECTIVE To describe the course and the 4-year outcome of juvenile spondyloarthritis (jSpA). METHODS Patients with a diagnosis of jSpA and an age at onset ≤16 years were included in the German Spondyloarthritis Inception cohort (GESPIC) and followed up prospectively for 4 years. RESULTS 118 patients (73% men, 66% HLA-B27 positive, mean age 13.5 years, mean symptom duration 2.2 years) were ...

2013
WA Sifuentes Giraldo CA Guillén Astete ML Gámir Gámir C Arnal Guimerá D Clemente Garulo I Calvo I Rotes J Sampedro Álvarez J García Consuegra M Medrano P Collado R Roldán S Bustabad

Introduction Juvenile spondyloarthritis (J-spa) is characterized by a predominantly peripheral involvement and more frequent presentation as undifferentiated forms. However, like its adult-onset equivalent, it has the potential to develop structural damage and evolve to juvenile ankylosing spondylitis (J-AS), with consequent functional impairment that will last for the lifetime of the patient. ...

Journal: :Annals of the rheumatic diseases 2004
N Barkham H Marzo-Ortega D McGonagle P Emery

P hysicians’ perceptions of the spondyloarthropathies are changing. Ankylosing spondylitis (AS), the prototype of this group, has traditionally been considered a rare disease with few therapeutic options. In addition, diagnosis is difficult, sometimes delayed for decades, mainly owing to the lack of sensitivity of the traditional imaging method, radiography, to detect the hallmark of AS, sacroi...

2014
Selin HASSAN Peyman YALÇIN Şebnem ATAMAN Nurben SÜLDÜR Selin Hassan

©2014 Turkish League Against Rheumatism. All rights reserved. Reactive arthritis is a seronegative, HLA-B27-linked spondyloarthropathy which occurs as a result of a pathogen, often of gastrointestinal or genitourinary origin, and triggers a cell-mediated immune response. In this article, we present a 64-yearold male case who developed reactive arthritis with fever and asymmetric oligoarthritis ...

2014
Praveen Kumar Darshan Singh Bhakuni Sangita Rastogi

Background Chlamydia trachomatis is a multifaceted, asymptomatic, most prevalent sexually transmitted pathogen worldwide. Due to lack of specific diagnostic methods for C. trachomatis in Spondyloarthropathy (SpA) patients, this pathogen is under diagnosed and under estimated in various countries including India. We aimed to estimate circulatory antibodies to chlamydial heat shock protein60 (chs...

2016
Yasemin Ozkan

Ankylosing spondylitis is one of the subgroup of diseases called "seronegative spondyloarthropathy". Frequently, it affects the vertebral colon and sacroiliac joint primarily and affects the peripheral joints less often. This chronic, inflammatory and rheumatic disease can also affect the extraarticular regions of the body. The extraarticular affections can be ophthalmologic, cardiac, pulmonary...

2012
Hwan Park Hong Ki Min Jae Ho Lee Hae Min Lee Eunsil Koh Ju Yeon Heo Jun-Ki Min Sung Hwan Park

Hematologic malignancies and lymphoproliferative disorders have been reported after using tumor necrosis factor-α inhibitor in patients suffering from spondyloarthropathy. Previously reported cases were treated by using infliximab and etanercept. Usually, it takes approximately several months for leukemia or lymphoproliferative disorders to occur after the application of those agents. However, ...

Journal: :Annals of the rheumatic diseases 1983
J Kovarsky

Treatment with a high-dose, intravenous bolus of methylprednisolone has been reported in numerous cases of rheumatic diseases. The optimal routes of administration, dosage, dosage interval, and other factors are unknown. This report describes uncontrolled clinical observations with a single dose of 320 mg of intramuscular methylprednisolone acetate in patients with rheumatic disease (12 with rh...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید